ACE2 and COVID-19: The variants identified by high-throughput genetic screening might affect COVID-19 by interfering with viral entry, by modulating antiviral immunity, or by modulating the renin–angiotensin system responsible for the regulation of blood pressure that SARS-CoV-2 interferes with through its binding to ACE2; for some other variants, the mechanistic link is less clear.